Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation; Stroke Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Testing effectiveness (Phase 2)Study completedNCT00645853
What this trial is testing

Long-term Safety in Atrial Fibrillation Patients

Who this might be right for
Persistent or Permanent Nonvalvular Atrial Fibrillation
AstraZeneca 523
Not applicableNot Yet RecruitingNCT06564012
What this trial is testing

Wearable Cardiac Monitor to Enhance Detection of Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation

Who this might be right for
Atrial FibrillationArrhythmias, CardiacHeart Diseases+2 more
Sunnybrook Health Sciences Centre 100
Testing effectiveness (Phase 2)Study completedNCT01997905
What this trial is testing

Stroke Feasibility Study

Who this might be right for
Atrial FibrillationAFib
AtriCure, Inc. 13
Not applicableStudy completedNCT01805531
What this trial is testing

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication

Who this might be right for
Atrial Fibrillation
Bayer 411
Testing effectiveness (Phase 2)Study completedNCT02998905
What this trial is testing

NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Population Health Research Institute 30
Not applicableStudy completedNCT02958943
What this trial is testing

Electronic Alerts for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
Brigham and Women's Hospital 798
Not applicableStudy completedNCT03563937
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon

Who this might be right for
Atrial Fibrillation
Bayer 64,920
Not applicableUnknownNCT02028130
What this trial is testing

Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation: A Safety and Feasibility Study

Who this might be right for
Persistent Atrial Fibrillation
Royal Brompton & Harefield NHS Foundation Trust 20
Not applicableStudy completedNCT02409654
What this trial is testing

Hong Kong Outpatient AF Screening Using Single-lead ECG Device

Who this might be right for
Atrial Fibrillation
Chinese University of Hong Kong 500
Not applicableStudy completedNCT03867227
What this trial is testing

Non-pharmacological Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Research Center for Preventive Medicine 300
Not applicableWithdrawnNCT03441022
What this trial is testing

Continuous Data Collection and Analysis for Stroke Prevention Using a Wearable Sensor

Who this might be right for
Atrial Fibrillation
Mayo Clinic
Not applicableStudy completedNCT02839746
What this trial is testing

Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 671
Not applicableStudy completedNCT04435769
What this trial is testing

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

Who this might be right for
Atrial Fibrillation
Pfizer 109
Not applicableStudy completedNCT01858779
What this trial is testing

Know Your Pulse Post Stroke-Measurement of Peripheral Pulse for Detection of Atrial Fibrillation After Ischemic Stroke

Who this might be right for
StrokeAtrial Fibrillation
University of Erlangen-Nürnberg Medical School 300
Not applicableStudy completedNCT02714855
What this trial is testing

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 2,081
Not applicableStudy completedNCT02849509
What this trial is testing

Patient Convenience Study- NIS RELATE

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,313
Not applicableStudy completedNCT02585076
What this trial is testing

A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension

Who this might be right for
HypertensionAtrial Fibrillation
Bayer 1,119
Early research (Phase 1)Study completedNCT05419635
What this trial is testing

Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Prevention of Thromboembolic EventsAtrial FibrillationAcute Myocardial Infarction+2 more
Bayer 27
Not applicableLooking for participantsNCT05900414
What this trial is testing

RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University of Calgary 60
Next Page